Tamsulosin Monotherapy versus Combination Therapy with Antibiotics or Anti-Inflammatory Agents in the Treatment of Chronic Pelvic Pain Syndrome
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 15 (2) , 92-96
Abstract
Chronic pelvic pain syndrome (CPPS) is treated by use of various protocols. We compared tamsulosin monotherapy with tamsulosin in combination with antibiotics or anti-inflammatory agents and evaluated the efficacy of these treatments in patients with CPPS. Patients (n=107) who were younger than 55 years and diagnosed with CPPS were randomly assigned to treatment with tamsulosin at 0.2 mg (group A), tamsulosin at 0.2 mg plus anti-inflammatory drugs (group B) or tamsulosin at 0.2 mg plus antibiotics (group C) daily. We applied the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) and the International Prostate Symptom Score (IPSS) to evaluate 100 patients who were treated for 12 weeks (7 withdrew). Scores of the three groups were compared by analysis of variance and we also evaluated subscores, which included pain, voiding and quality of life (QoL). All three groups showed statistically significant decreases in NIH-CPSI score, IPSS and subscore scores (P<0.05). There were no statistically significant differences between the groups except for the QoL domain of the IPSS (group A vs. C; P<0.01). Tamsulosin monotherapy for 12 weeks was effective for treating patients with CPPS, compared with combination therapy with antibiotics or anti-inflammatory drugs.Keywords
This publication has 28 references indexed in Scilit:
- The Present and Future of ProstatitisKorean Journal of Urology, 2008
- Comparison of the Efficacy of Antibiotic Monotherapy and Antibiotic Plus Alpha-blocker Combination Therapy for Patients with Inflammatory Chronic Prostatitis/Chronic Pelvic Pain SyndromeKorean Journal of Urology, 2008
- BENIGN PROSTATIC HYPERPLASIA CELL LINE VIABILITY AND MODULATION OF JM-27 BY DOXAZOSIN AND IBUPROFENJournal of Urology, 2005
- A randomized placebo‐controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)BJU International, 2004
- A Randomized, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rofecoxib in the Treatment of Chronic Nonbacterial ProstatitisJournal of Urology, 2003
- Long-term Results of Multimodal Therapy for Chronic Prostatitis/chronic Pelvic Pain SyndromeJournal of Urology, 2003
- Terazosin Therapy For Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Placebo Controlled TrialJournal of Urology, 2003
- PREDICTORS OF PATIENT RESPONSE TO ANTIBIOTIC THERAPY FOR THE CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: A PROSPECTIVE MULTICENTER CLINICAL TRIALJournal of Urology, 2001
- Prostatodynia—Physiological Characteristics and Rational Management with Muscle RelaxantsBritish Journal of Urology, 1981
- Anatomical Factors in ProstatitisBritish Journal of Urology, 1974